Recombinant FOLR1 (Mirvetuximab Biosimilar) antibody
The Human Chimeric anti-FOLR1 (Mirvetuximab Biosimilar) antibody (ABIN7538071) specifically detects FOLR1 (Mirvetuximab Biosimilar) in ELISA and WB.
The antibody is reactive with Human samples.
Catalog No. ABIN7538071
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant FOLR1 (Mirvetuximab Biosimilar) antibody (ABIN7538071)
Target
FOLR1 (Mirvetuximab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Chimeric
Conjugate
This FOLR1 (Mirvetuximab Biosimilar) antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Mirvetuximab Biosimilar - Anti-FOLR1 mAb - Research Grade
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG1 kappa
-
-
anti-FOLR1 (Mirvetuximab Biosimilar) (E239D), (M241L) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Mouse Chimeric unconjugated
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- FOLR1 (Mirvetuximab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Mirvetuximab is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of novel folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research.
-
CAS-No
- 1453084-36-0
Target
-
You are here:
